Coronavirus 3CLpro proteinase cleavage sites: Possible relevance to SARS virus pathology

BMC Bioinformatics

Volumn 5, Issue , 2004, Pages

  Kiemer, Lars ^a   Lund, Ole ^a   Brunak, Søren ^a   Blom, Nikolaj ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLEAVAGE SITES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORS; HIGH SPECIFICITY; POSSIBLE FUTURES; PREDICTION METHODS; PROTEINASE INHIBITORS; PROTEOLYTIC CLEAVAGE; SEVERE ACUTE RESPIRATORY SYNDROME;

FORECASTING; PATHOLOGY; PROTEINS; VIRUSES;

DISEASES;

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; POLYPROTEIN; PROTEINASE; PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN; 3C-LIKE PROTEINASE, CORONAVIRUS; CYSTEINE PROTEINASE; PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BAYES THEOREM; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; ARTIFICIAL INTELLIGENCE; BINDING SITE; CORONAVIRUS; DNA SEQUENCE; ENZYMOLOGY; GENETICS; METABOLISM; PATHOGENICITY; PATHOLOGY; PROCEDURES; VIROLOGY;

CORONAVIRUS; SARS CORONAVIRUS;

ARTIFICIAL INTELLIGENCE; BINDING SITES; CORONAVIRUS 229E, HUMAN; CYSTEINE ENDOPEPTIDASES; HUMANS; NEURAL NETWORKS (COMPUTER); PROTEINS; SARS VIRUS; SEQUENCE ANALYSIS, DNA; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 13244289882     PISSN: 14712105     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2105-5-72     Document Type: Article

References (38)

1. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD: Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423:240.
2. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL: The Genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-1404.
3. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen Mh, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TCT, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus ADME, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ: Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. Science 2003, 300(5624):1394-1399.
4. Denison MR, Zoltick PW, Leibowitz JL, Pachuk CJ, Weiss SR: Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59. J Virol 1991, 65:3076-3082.
5. Ziebuhr J, Herold J, Siddell SG: Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity. J Virol 1995, 69:4331-4338.
6. Denison MR, Kim JC, Ross T: Inhibition of coronavirus MHV-A59 replication by proteinase inhibitors. Adv Exp Med Biol 1995, 380:391-397.
7. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R: Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300:1763-1767.
8. Holmes KV, Enjuanes L: Virology. The SARS coronavirus: a postgenomic era. Science 2003, 300:1377-1378.
9. Urzainqui A, Carrasco L: Degradation of cellular proteins during poliovirus infection: studies by two-dimensional gel electrophoresis. J Virol 1989, 63:4729-4735.
10. Blom N, Hansen J, Blaas D, Brunak S: Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci 1996, 5:2203-2216.
11. Badorff C, Berkely N, Mehrotra S, Talhouk JW, Rhoads RE, Knowlton KU: Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 2000, 275:11191-11197.
12. Thiel V, Ivanov KA, Putics A, Hertzig T, Schelle B, Bayer S, Weissbrich B, Snijder EJ, Rabenau H, Doerr HW, Gorbalenya AE, Ziebuhr J: Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 2003, 84:2305-2315.
13. Berger A, Schechter I: Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci 1970, 257:249-264.
14. Ziebuhr J, Snijder EJ, Gorbalenya AE: Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 2000, 81:853-879.
15. Hegyi A, Ziebuhr J: Conservation of substrate specificities among coronavirus main proteases. J Gen Virol 2002, 83:595-599.
16. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M: The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 2003, 31:365-370.
17. Lamphear BJ, Kirchweger R, Skern T, Rhoads RE: Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 1995, 270:21975-21983.
18. Clark ME, Dasgupta A: A transcriptionally active form of TFIIIC is modified in poliovirus-infected HeLa cells. Mol Cell Biol 1990, 10:5106-5113.
19. Clark ME, Hammerle T, Wimmer E, Dasgupta A: Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J 1991, 10:2941-2947.
20. Shen Y, Igo M, Yalamanchili P, Berk AJ, Dasgupta A: DNA binding domain and subunit interactions of transcription factor IIIC revealed by dissection with poliovirus 3C protease. Mol Cell Biol 1996, 16:4163-4171.
21. Yalamanchili P, Datta U, Dasgupta A: Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol 1997, 71: 220-1226.
22. Yalamanchili P, Weidman K, Dasgupta A: Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro. Virology 1997, 239:176-185.
23. Kliewer S, Dasgupta A: An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID. Mol Cell Biol 1988, 8: 175-3182.
24. Weidman MK, Yalamanchili P, Ng B, Tsai W, Dasgupta A: Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 2001, 291: 60-271.
25. Iwabuchi K, Li B, Massa HF, Trask BJ, Date T, Fields S: Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J Biol Chem 1998, 273: 6061-26068.
26. Joachims M, Etchison D: Poliovirus infection results in structural alteration of a microtubule-associated protein. J Virol 1992, 66:5797-5804.
27. Joachims M, Harris KS, Etchison D: Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. Virology 1995, 211:451-461.
28. Johnson MD, Widdicombe JH, Allen L, Barbry P, Dobbs LG: Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A 2002, 99: 966-1971.
29. Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C: Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003, 37:1180-1188.
30. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW: Treatment of SARS with human interferons. Lancet 2003, 362:293-294.
31. Gao F, Ou HY, Chen LL, Zheng WX, Zhang CT: Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett 2003, 553:451-456.
32. Chou KC, Wei DQ, Zhong WZ: Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun 2003, 308: 48-151.
33. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL: GenBank: update. Nucleic Acids Res 2004:D23-26.
34. Shannon CE: A mathematical theory of communication. Bell System Tech J 1948, 27:379-423. 623-656
35. Schneider TD, Stephens RM: Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 1990, 18: 097-6100.
36. Nielsen H, Engelbrecht J, Brunak S, von Heijne G: Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997, 10: -6.
37. Blom N, Gammeltoft S, Brunak S: Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999, 294:1351-1362.
38. Matthews BW: Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 1975, 405:442-451.